Hamburgisches Forschungsinstitut fuer Chronisch Entzuendliche Darmerkrankungen

Hamburg

1 studies enrolling now · 1 studies all time

What they study most

Moderately to Severely Active Crohn Disease

Studies at this site

• Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease — Recruiting now